Singapore markets closed
Straits Times Index
3,256.82 -12.45 (-0.38%) S&P 500
4,266.20 -13.95 (-0.33%) Dow
33,710.69 -50.36 (-0.15%) Nasdaq
13,008.05 -39.14 (-0.30%) BTC-USD
24,099.49 -407.10 (-1.66%) CMC Crypto 200
572.27 -18.49 (-3.13%)
PFE Aug 2022 48.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:44PM EDT. Market open.
| Previous close | 0.2500 |
| Open | 0.0400 |
| Bid | 0.0000 |
| Ask | 0.0100 |
| Strike | 48.00 |
| Expiry date | 2022-08-12 |
| Day's range | 0.0100 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.89k |
- Motley Fool
1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)
On that note, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) worked together to develop and commercialize their coronavirus vaccine, Comirnaty. In BioNTech's second quarter, practically 100% of its product sales, totaling around $3.3 billion, were attributable to its share of jab revenue.
- Zacks
Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails
Currently, Novavax (NVAX) has only one marketed product in its portfolio, its protein-based COVID-19 vaccine. However, it is lagging in competition behind mRNA-based vaccines.
- Zacks
Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar?
Style Box ETF report for RDVY
© 2022 Yahoo. All rights reserved.
